Stocks · Health care · Surgical & Medical Instruments & Apparatus

NovoCure Ltd

NVCR Clue Score34
Fiscal year ends December CIK 0001645113 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Ashley Cordova
5 Sep 2025
Chief Executive Officer
Buy
81,550
$12.22
$996.86K
Christoph Brackmann
29 Jul 2025
Chief Financial Officer
Buy
5,000
$11.50
$57.50K
Christoph Brackmann
29 Jul 2025
Chief Financial Officer
Buy
5,000
$11.60
$58.00K
Christoph Brackmann
29 Jul 2025
Chief Financial Officer
Buy
10,000
$11.63
$116.30K
Asaf Danziger
26 Nov 2021
Chief Executive Officer
Buy
104
$96.50
$10.04K
Asaf Danziger
26 Nov 2021
Chief Executive Officer
Buy
1,000
$103.37
$103.37K
Asaf Danziger
26 Nov 2021
Chief Executive Officer
Buy
3,870
$102.36
$396.13K
Showing 250 of 970 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 688
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 414
Sales at will 468
Transactions with no price 2
Shares from compensation/vesting 43,129,995
Sales filed before the plan box existed 394
History held since 5 Oct 2015